"The U.S. Food and Drug Administration today approved Liposorber LA-15 System to treat pediatric patients with primary focal segmental glomerulosclerosis (FSGS) either before transplant, or after renal (kidney) transplantation in which there is re"...
- Clinician Information:
PrismaSol Solution Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
PrismaSol Solution (sterile hemofiltration/hemodiafiltration solution) is an electrolyte and buffer solution used as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace plasma volume removed by ultrafiltration and to correct electrolytes and acid-base imbalances. PrismaSol solution may also be used in cases of drug poisoning when CRRT is used to remove filterable substances. Common side effects include fluid imbalance and disturbances in electrolyte, acid-base and glucose balance.
The mode of therapy, solute formulation, flow rates and length of therapy with PrismaSol Solution is selected by a doctor depending on the clinical condition of the patient as well as the patient's fluid, electrolyte, acid-base and glucose balance. PrismaSol Solution may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using PrismaSol Solution. Consult your doctor before breastfeeding.
Our PrismaSol Solution (sterile hemofiltration/hemodiafiltration solution) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
PrismaSol Solution FDA Prescribing Information: Side Effects
Adverse reactions can result from the solution or the CRRT procedure.
Read the entire FDA prescribing information for PrismaSol Solution (Sterile Hemofiltration Hemodiafiltration Solution) »
Additional PrismaSol Solution Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.